Indoco Remedies: Here’s why Vinit Bolinjkar is bullish on Indoco Remedies
“So, given that kind of environment, I believe that Indoco Remedies is a stock which is going very cheap, available at cheap valuations and the management is pretty well embedded in the business, they have been around for 30 years,” says Vinit Bolinjkar, Ventura Securities.A view on the pharma space in AstraZeneca, Lupin, Laurus, Zydus … Read more
